Genetic Technologies (AU:GTG) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Genetic Technologies Limited has successfully completed the sale of its geneType business and assets to Rhythm Biosciences, marking a significant move in the genomic diagnostics sector. The transaction, finalized on December 23, 2024, involves a seamless transition with the support of both companies. This development reflects ongoing shifts in the market as companies adapt and restructure towards innovative growth.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue